" I can't complain , but sometimes I still do . "
Recent BTAI News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 11:21:25 AM
- BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI® Approval in Outpatient Setting • GlobeNewswire Inc. • 03/27/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 12:05:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 12:03:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 12:01:16 AM
- BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering • GlobeNewswire Inc. • 03/11/2026 08:20:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/11/2026 12:09:22 PM
- BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering • GlobeNewswire Inc. • 03/10/2026 06:36:00 PM
- BioXcel posts encouraging Phase 2 results for opioid withdrawal therapy BXCL501 • IH Market News • 03/05/2026 02:53:56 PM
- BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal • GlobeNewswire Inc. • 03/05/2026 12:00:00 PM
- BioXcel Therapeutics to Host Virtual Roundtable Featuring Leading Medical Experts Addressing Latest Developments in Treatment of Acute Agitation in Alzheimer’s Dementia • GlobeNewswire Inc. • 02/19/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 12:05:34 PM
- BioXcel Therapeutics Completes Market Opportunity Assessment and Advances Commercialization Plans for IGALMI® in the At-Home Setting • GlobeNewswire Inc. • 02/12/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 10:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 12:00:40 PM
- BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI® Label Expansion in the At-Home Setting • GlobeNewswire Inc. • 01/20/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 12:09:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 12:01:13 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 12:02:13 PM
- BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting • GlobeNewswire Inc. • 01/12/2026 12:00:00 PM
- BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI® • GlobeNewswire Inc. • 01/07/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 01:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 01:02:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 01:00:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 09:30:34 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
